[LHN]
Subscribe
Open menu
MethodologySubmit a ClaimMedical Disclaimer

BPC-157 vs TB-500: what is the difference?

Two popular recovery peptides, two different evidence questions.

Updated Jun 27, 2026 · Last checked Jun 27, 2026 · 5 min read

Simple answer

BPC-157 and TB-500 are often grouped together because both are marketed for recovery. They are not the same compound, and neither has strong human evidence for broad gym-injury recovery. BPC-157 claims lean on BPC repair biology; TB-500 claims often borrow from thymosin beta-4 biology.

At a glance

Evidence:Mostly lab/animalRisk:High riskStatus:Not approved

What matters first

  • BPC-157 and TB-500 are often grouped together because both are marketed for recovery. They are not the same compound, and neither has strong human evidence for broad gym-injury recovery. BPC-157 claims lean on BPC repair biology; TB-500 claims often borrow from thymosin beta-4 biology.
  • Look for human evidence and exact approved-use language before trusting a longevity claim.
  • Use this page to ask better questions, not as a personal medical plan.

What people usually mean

  • They may mean a regulated medicine, a compounded product, a clinic service, a clinical trial or an unapproved internet product.
  • Those categories carry very different evidence, legal and quality questions.

What we know

  • The biology may be interesting, but the consumer claim needs direct human evidence.
  • Approval status is use-specific and does not travel automatically to anti-aging or recovery claims.

What we do not know

  • Whether the claim improves meaningful outcomes in the exact population being marketed to.
  • Whether products discussed online match the materials studied in source literature.

What should you do with this information?

  • Use it to ask better questions, not to self-experiment.
  • Do not use this page for dosing, sourcing, stacking or self-administration decisions.
  • Speak with a qualified clinician before acting on high-risk claims.

What not to do

  • Do not use this page for dosing, sourcing, reconstitution, cycle planning, stacking or self-administration decisions.
  • Do not use research chemicals as medicines.
  • Do not copy social-media protocols or clinic marketing without qualified medical review.
  • Do not treat a regulatory review, animal study or mechanism paper as proof of personal benefit.

Questions to ask a qualified clinician

  1. What exact condition or outcome is being discussed, and is the product approved for that use?
  2. What human evidence exists for this specific question, not just related biology?
  3. What are the known contraindications, interactions, monitoring needs and alternatives?
  4. How would benefit, no benefit or harm be measured?
  5. Who is responsible for follow-up and adverse-event reporting?
Show the evidenceSources, limitations, safety context and deeper notes.+
Pubmed

A musculoskeletal review focused on the promise and risk gap around BPC-157 rather than treating injury recovery as settled.

Publisher
Current Reviews in Musculoskeletal Medicine
Accessed
Jun 27, 2026
Study type
Systematic Review

Limitations: Narrative reviews synthesize existing literature; they do not replace controlled human injury trials.

Pubmed

Systematic review of BPC-157 in orthopaedic sports medicine, useful for explaining why interest exists and where human evidence is thin.

Publisher
HSS Journal
Accessed
Jun 27, 2026
Study type
Systematic Review

Limitations: A review can map the evidence base but cannot establish benefit where underlying human trials are limited.

Red flags

  • A claim says or implies FDA approval for anti-aging, recovery or performance without a product-specific label.
  • A page sells urgency, miracle language or a bundled stack before explaining risk.
  • The offer relies on testimonials instead of human clinical evidence.
  • The product identity, pharmacy, clinician credentials or adverse-event process is unclear.
  • The source material is a social clip, forum thread or sales page with no primary evidence.

Simple answer

BPC-157 and TB-500 are often grouped together because both are marketed for recovery. They are not the same compound, and neither has strong human evidence for broad gym-injury recovery. BPC-157 claims lean on BPC repair biology; TB-500 claims often borrow from thymosin beta-4 biology.

What people usually mean

What we know

What we do not know

Safe reading

What not to do

  • Do not use this page for dosing, sourcing, reconstitution, cycle planning, stacking or self-administration decisions.
  • Do not use research chemicals as medicines.
  • Do not copy social-media protocols or clinic marketing without qualified medical review.
  • Do not treat a regulatory review, animal study or mechanism paper as proof of personal benefit.

Questions to ask a qualified clinician

  • What exact condition or outcome is being discussed, and is the product approved for that use?
  • What human evidence exists for this specific question, not just related biology?
  • What are the known contraindications, interactions, monitoring needs and alternatives?
  • How would benefit, no benefit or harm be measured?
  • Who is responsible for follow-up and adverse-event reporting?

FAQs

Does this page give a protocol?

No. LHN explains evidence, risk and regulatory context. It does not provide dosing, sourcing, self-administration or personal medical instructions.

Why are source links included?

So readers can see whether a claim is based on official guidance, human research, animal studies, mechanisms, commercial marketing or anecdotes.

Get the weekly longevity evidence briefing.

One plain-English email on the claims, studies and regulatory updates worth knowing - without protocols, hype or miracle claims.

No protocols. No miracle claims. No spam.

I'm new to longevityPeptides and regulationRapamycin and longevity drugsNAD and supplementsGene therapy frontierBiological age and testing